These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. [Prognostic value of gene expression profiling using cDNA arrays in lymphomas]. Bertucci F; Salas S; Nasser V; Houlgatte R; Birnbaum D; Xerri L Bull Cancer; 2002; 89(7-8):661-5. PubMed ID: 12206978 [TBL] [Abstract][Full Text] [Related]
28. Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma. Banham AH; Connors JM; Brown PJ; Cordell JL; Ott G; Sreenivasan G; Farinha P; Horsman DE; Gascoyne RD Clin Cancer Res; 2005 Feb; 11(3):1065-72. PubMed ID: 15709173 [TBL] [Abstract][Full Text] [Related]
29. Diffuse large B-cell lymphoma with overexpression of cyclin e substantiates poor standard treatment response and inferior outcome. Tzankov A; Gschwendtner A; Augustin F; Fiegl M; Obermann EC; Dirnhofer S; Went P Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2125-32. PubMed ID: 16609025 [TBL] [Abstract][Full Text] [Related]
30. Intravascular large B-cell lymphoma. Sugimoto KJ; Mori KL; Oshimi K Am J Hematol; 2004 Jul; 76(3):291-2. PubMed ID: 15224370 [No Abstract] [Full Text] [Related]
31. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma]. Kovrigina AM; Probatova NA Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291 [TBL] [Abstract][Full Text] [Related]
32. The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma. Goy A; Stewart J; Barkoh BA; Remache YK; Katz R; Sneige N; Gilles F Cancer; 2006 Feb; 108(1):10-20. PubMed ID: 16329118 [TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma. Eser B; Sari I; Canoz O; Altuntas F; Cakmak E; Ozturk A; Ozkan M; Er O; Cetin M; Unal A Am J Hematol; 2006 May; 81(5):307-14. PubMed ID: 16628716 [TBL] [Abstract][Full Text] [Related]
35. Primary diffuse large B-cell lymphoma of the skin. Lazaris AC; Nonni A; Pathiaki I; Patsouris E Dermatol Online J; 2006 May; 12(4):16. PubMed ID: 17083871 [TBL] [Abstract][Full Text] [Related]
36. The irreplaceable image: B-cell lymphoma of the gallbladder. Chim CS; Ooi CG Haematologica; 2001 Oct; 86(10):1119. PubMed ID: 11602429 [No Abstract] [Full Text] [Related]
37. Identification of TCL1A as an immunohistochemical marker of adverse outcome in diffuse large B-cell lymphomas. Ramuz O; Bouabdallah R; Devilard E; Borie N; Groulet-Martinec A; Bardou VJ; Brousset P; Bertucci F; Birg F; Birnbaum D; Xerri L Int J Oncol; 2005 Jan; 26(1):151-7. PubMed ID: 15586235 [TBL] [Abstract][Full Text] [Related]
38. [Detection for subtype-specific genomic/genetic alterations in diffuse large B-cell lymphoma (DLBCL)]. Tagawa H Rinsho Ketsueki; 2008 Feb; 49(2):73-81. PubMed ID: 18341036 [No Abstract] [Full Text] [Related]
39. Fas expression in DLBCL. Piana de Andrade V; Soares FA Am J Hematol; 2007 Apr; 82(4):331-2. PubMed ID: 17019688 [No Abstract] [Full Text] [Related]
40. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas. Piccaluga PP; Califano A; Klein U; Agostinelli C; Bellosillo B; Gimeno E; Serrano S; Solè F; Zang Y; Falini B; Zinzani PL; Pileri SA Haematologica; 2008 Jul; 93(7):1033-8. PubMed ID: 18492688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]